Adverum Biotechnologies (ADVM)
(Delayed Data from NSDQ)
$6.70 USD
-0.02 (-0.30%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $6.70 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-1.27 | 0.00% |
Earnings Summary
For their last quarter, Adverum Biotechnologies (ADVM) reported earnings of -$1.50 per share, missing the Zacks Consensus Estimate of -$1.28 per share. This reflects a negative earnings surprise of 17.19%. Look out for ADVM's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$1.27 per share, reflecting a year-over-year increase of 59.03%.
Earnings History
Price & Consensus
Zacks News for ADVM
Is a Beat in the Cards for Incyte (INCY) in Q2 Earnings?
ADVM: What are Zacks experts saying now?
Zacks Private Portfolio Services